Incidence of acute kidney injury after teicoplanin– or vancomycin– and piperacillin/tazobactam combination therapy: A comparative study using propensity score matching analysis
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Pharmacology (medical),Microbiology (medical)
Reference23 articles.
1. Optimizing antimicrobial therapy of sepsis and septic shock: focus on antibiotic combination therapy;Vazquez-Grande;Semin Respir Crit Care Med,2015
2. Beta-lactam combination therapy for the treatment of staphylococcus aureus and enterococcus species bacteremia: a summary and appraisal of the evidence;Bartash;Int J Infect Dis,2017
3. Combination of vancomycin and beta-lactam therapy for methicillin-resistant staphylococcus aureus bacteremia: a pilot multicenter randomized controlled trial;Davis;Clin Infect Dis,2016
4. Beta-lactams enhance vancomycin activity against methicillin-resistant staphylococcus aureus bacteremia compared to vancomycin alone;Dilworth;Antimicrob Agents Chemother,2014
5. Emerging infections program healthcare-associated infections and antimicrobial use prevalence survey team. Prevalence of antimicrobial use in US acute care hospitals;Magill;J Am Med Assoc,2014
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Risk Factors for Teicoplanin-Associated Acute Kidney Injury in Patients with Hematological Malignancies: Focusing on Concomitant Use of Tazobactam/Piperacillin;Biological and Pharmaceutical Bulletin;2024-05-18
2. Predictive model of acute kidney injury after spontaneous intracerebral hemorrhage: A multicenter retrospective study;European Stroke Journal;2023-06-27
3. Hesperetin attenuates teicoplanin-induced acute kidney injury by mitigating oxidative stress and inflammation in Wistar rats;Redox Experimental Medicine;2022-12-01
4. Influence of pharmacists and infection control teams or antimicrobial stewardship teams on the safety and efficacy of vancomycin: A Japanese administrative claims database study;PLOS ONE;2022-09-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3